10:15 AM EDT, 04/22/2024 (MT Newswires) -- Plus Therapeutics ( PSTV ) said Monday it has been selected for a $3 million funding recommendation from the US Department of Defense office of the Congressionally Directed Medical Research Programs.

The award is expected to start in Q3 and will help expand its clinical trial for pediatric brain cancer, the company said.

Shares of Plus Therapeutics ( PSTV ) were up more than 1% in recent trading.